Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Diagnos Inc V.ADK

Alternate Symbol(s):  DGNOF

Diagnos Inc. is a Canadian company, which is engaged in early detection of critical health problems based on its FLAIRE artificial intelligence (AI) platform. FLAIRE allows for quick modifying and developing of applications, such as computer assisted retina analysis (CARA). CARA’s image enhancement algorithms provide sharper, clearer and easier-to-analyze retinal images. CARA is a tool for real-time screening of large volumes of patients. It provides software-based services to assist health specialists in the detection of diabetic retinopathy and other eye-related pathologies. Its geographical areas include Canada, the United States of America, Mexico, and Chile. The Company’s subsidiaries include Diagnos Internacional SA de CV and Diagnos Healthcare (India) Private Limited.


TSXV:ADK - Post by User

Bullboard Posts
Comment by invertedhammeron May 21, 2015 11:47am
27 Views
Post# 23750783

RE:Very quiet

RE:Very quietSo true... besides, one can't predict what has already happened. However, isn't the goal of TA to predict where the stock is going based on where it has been? Discussions on company and stock activity, past and present, is crucial in understanding market sentiment and possible outcomes. Speaking of which... based on the trading these past few days I am realizing an error in my analysis of the pattern. I still believe an ascending base is developing but I was calculating .10 to be the third high. Now that the pattern has developed further I can see that the third high is .105 and we are currently in the third drop. It doesn't look like we'll be moving sideways for too long... first drop was 5 weeks, second drop was 3... I'm not expecting this one to be as long. next week? A new significant  contract followed by positive ye, a promising outlook for this year and stellar first quarter results can easily push this stock into the .30s by August, imo. I'm not one hundred percent on this but I think the timeframe to profitability for Diagnos is 18 months.
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse